AVTE
Price
$2.68
Change
-$0.04 (-1.47%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
78.84M
24 days until earnings call
BEAM
Price
$19.53
Change
-$0.64 (-3.17%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
2.03B
18 days until earnings call
Ad is loading...

AVTE vs BEAM

Header iconAVTE vs BEAM Comparison
Open Charts AVTE vs BEAMBanner chart's image
Aerovate Therapeutics
Price$2.68
Change-$0.04 (-1.47%)
Volume$8.18K
Capitalization78.84M
Beam Therapeutics
Price$19.53
Change-$0.64 (-3.17%)
Volume$18.23K
Capitalization2.03B
AVTE vs BEAM Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. BEAM commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a Hold and BEAM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (AVTE: $2.72 vs. BEAM: $20.17)
Brand notoriety: AVTE and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 1744% vs. BEAM: 69%
Market capitalization -- AVTE: $78.84M vs. BEAM: $2.03B
AVTE [@Biotechnology] is valued at $78.84M. BEAM’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • AVTE’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTE is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 7 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • AVTE’s TA Score: 7 bullish, 4 bearish.
  • BEAM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AVTE is a better buy in the short-term than BEAM.

Price Growth

AVTE (@Biotechnology) experienced а -1.09% price change this week, while BEAM (@Biotechnology) price change was +18.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

AVTE is expected to report earnings on Aug 11, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.03B) has a higher market cap than AVTE($78.8M). AVTE YTD gains are higher at: 2.642 vs. BEAM (-18.669). AVTE has higher annual earnings (EBITDA): -89.96M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. AVTE (88.7M). AVTE has less debt than BEAM: AVTE (540K) vs BEAM (161M). BEAM has higher revenues than AVTE: BEAM (63.5M) vs AVTE (0).
AVTEBEAMAVTE / BEAM
Capitalization78.8M2.03B4%
EBITDA-89.96M-383.98M23%
Gain YTD2.642-18.669-14%
P/E RatioN/AN/A-
Revenue063.5M-
Total Cash88.7M851M10%
Total Debt540K161M0%
TECHNICAL ANALYSIS
Technical Analysis
AVTEBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 22 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EICIX17.28N/A
N/A
EIC Value Institutional
FCCNX67.62N/A
N/A
Fidelity Advisor Canada C
NSMAX28.47N/A
N/A
Nuveen Small/Mid-Cap Value A
OIEPX22.59N/A
N/A
JPMorgan Equity Income R3
BGESX12.43N/A
N/A
Baillie Gifford International Growth I

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
-0.73%
OVID - AVTE
89%
Closely correlated
+3.63%
NTLA - AVTE
46%
Loosely correlated
+1.11%
DNLI - AVTE
43%
Loosely correlated
+4.17%
BEAM - AVTE
41%
Loosely correlated
+1.51%
SNDX - AVTE
39%
Loosely correlated
+2.31%
More